Huang YH - Search Results

1

Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial.

Liu J, Gao LD, Fu B, Yang HT, Zhang L, Che SQ, Xu Y, Du X, Liu ZC, Xue Y, Lv CX, Huang YH, Wang BH, Gao SX, Xing YF, Yuan XH. Liu J, et al. Among authors: huang yh. Phytomedicine. 2022 Jun;100:154079. doi: 10.1016/j.phymed.2022.154079. Epub 2022 Apr 2. Phytomedicine. 2022. PMID: 35413644 Clinical Trial.

2

A randomized double-blind placebo-controlled trial of a Chinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women.

Xia Y, Zhao Y, Ren M, Zhang J, Wang Y, Chang Y, Fu S, Fan G, Zhu Y, Huang Y, Gao X. Xia Y, et al. Menopause. 2012 Feb;19(2):234-44. doi: 10.1097/gme.0b013e3182273177. Menopause. 2012. PMID: 22089177 Clinical Trial.

3

Comparison of scaled-average, population, and individual bioequivalence on 2 tablets of pitavastatin calcium: a 3-period, reference-replicated, crossover study in healthy Chinese volunteers.

Huang YH, Li ZQ, Pan GX, Li YF, Liu Y, Sun JX, Gu XF, Li N, Wang BH. Huang YH, et al. Clin Ther. 2014 Sep 1;36(9):1205-1216.e6. doi: 10.1016/j.clinthera.2014.06.021. Clin Ther. 2014. PMID: 25234550

4

A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine granules for the treatment of menopausal symptoms by stages.

Fu SF, Zhao YQ, Ren M, Zhang JH, Wang YF, Han LF, Chang YX, Fan GW, Wang H, Huang YH, Zhai JB, Dong JY, Li X, Ai JQ, Zhang H, Zhu Y, Zhang BL, Sun LK, Fan X, Gao XM. Fu SF, et al. Among authors: huang yh. Menopause. 2016 Mar;23(3):311-23. doi: 10.1097/GME.0000000000000534. Menopause. 2016. PMID: 26671188 Clinical Trial.

5

[Progress on studies of impact on CYP450 enzymes activity of traditional Chinese medicine by Cocktail probe substrates approach].

Du X, He X, Huang YH, Li ZQ. Du X, et al. Among authors: huang yh. Zhongguo Zhong Yao Za Zhi. 2016 Dec;41(24):4541-4549. doi: 10.4268/cjcmm20162410. Zhongguo Zhong Yao Za Zhi. 2016. PMID: 28936835 Review. Chinese.

6

[Expert consensus on the design and implementation of clinical safety centralized monitoring study of Chinese medical injection].

Zhang JH, Ren JT, Hu JQ, Xie YM, Song HB, Zhu MJ, Gao R, Wang Z, Zheng WK, Li XL, Jiang M, Huang YH, Lu F, He LY, Lian WX, Yang ZQ, Yuan WA, Hu SY, Wang BH, Wang WL, Ren DQ, Zhang BL; Clinical Pharmacology Committee of the China Association of Chinese Medicine; Clinical Curative Effect Evaluation Committee of the World Federation of Chinese Medicine Societies. Zhang JH, et al. Among authors: huang yh. Zhongguo Zhong Yao Za Zhi. 2017 Jan;42(1):6-9. doi: 10.19540/j.cnki.cjcmm.2017.0003. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 28945018 Chinese.

7

The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation.

Lv C, Liu C, Yao Z, Gao X, Sun L, Liu J, Song H, Li Z, Du X, Sun J, Li Y, Ye K, Wang R, Huang Y. Lv C, et al. Front Pharmacol. 2017 Nov 21;8:826. doi: 10.3389/fphar.2017.00826. eCollection 2017. Front Pharmacol. 2017. PMID: 29209208 Free PMC article.

8

Nuciferine and paeoniflorin can be quality markers of Tangzhiqing tablet, a Chinese traditional patent medicine, based on the qualitative, quantitative and dose-exposure-response analysis.

Li Z, Liu J, Zhang D, Du X, Han L, Lv C, Li Y, Wang R, Wang B, Huang Y. Li Z, et al. Phytomedicine. 2018 May 15;44:155-163. doi: 10.1016/j.phymed.2018.02.006. Epub 2018 Feb 21. Phytomedicine. 2018. PMID: 29519686 Clinical Trial.

9

Identify super quality markers from prototype-based pharmacokinetic markers of Tangzhiqing tablet (TZQ) based on in vitro dissolution/ permeation and in vivo absorption correlations.

Li Z, Liu J, Li Y, Du X, Li Y, Wang R, Lv C, He X, Wang B, Huang Y, Zhang D. Li Z, et al. Phytomedicine. 2018 Jun 1;45:59-67. doi: 10.1016/j.phymed.2018.04.001. Epub 2018 Apr 4. Phytomedicine. 2018. PMID: 29685365 Clinical Trial.

10

Metabolomics-Based Clinical Efficacy and Effect on the Endogenous Metabolites of Tangzhiqing Tablet, a Chinese Patent Medicine for Type 2 Diabetes Mellitus with Hypertriglyceridemia.

Liu J, Li Z, Liu H, Wang X, Lv C, Wang R, Zhang D, Li Y, Du X, Li Y, Wang B, Huang Y. Liu J, et al. Evid Based Complement Alternat Med. 2018 Jul 24;2018:5490491. doi: 10.1155/2018/5490491. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30140295 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,427 results

Search Page